Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashkan Rezazadeh Ardabili

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Crohn'S & Colitis|May 14, 2021
Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn's DiseaseAshkan Rezazadeh Ardabili, Danny Goudkade, Dion Wintjens, et al.
Alimentary Pharmacology & Therapeutics|July 7, 2022
Classic drugs in the time of new drugs: real-world, long-term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel diseaseAshkan Rezazadeh Ardabili, Steven Jeuring, Zlatan Mujagic, et al.
Digestive Diseases and Sciences|May 24, 2026
Healthcare Providers' Perspectives on the Role of Artificial Intelligence in the Care of Patients with Inflammatory Bowel Disease: An International SurveyJalpa Devi, Colleen Y Colbert, Sophia Haroon Dar, et al.
Plos One|October 5, 2021
Severe COVID-19 in inflammatory bowel disease patients in a population-based settingRob H Creemers, Ashkan Rezazadeh Ardabili, Daisy M Jonkers, et al.
Pediatric Research|July 30, 2024
Explorative study on the value of hepcidin in predicting iron non-responsiveness in paediatric inflammatory bowel diseaseNanja Bevers, Arta Aliu, Ashkan Rezazadeh Ardabili, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2024
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remissionArta Aliu, Daan H C A Bosch, Daniel Keszthelyi, et al.
Journal of Crohn'S & Colitis|July 8, 2025
The Risk of Mild, Moderate, and Severe Infections in IBD patients - A prospective, multicentre observational cohort study (PRIQ)Ashkan Rezazadeh Ardabili, Dirk Van Esser, Dion Wintjens, et al.
Journal of Crohn'S & Colitis|February 16, 2023
Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel DiseaseAshkan Rezazadeh Ardabili, Dirk van Esser, Dion Wintjens, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 26, 2023
Fatigue and Physical Activity Patterns in Children With Inflammatory Bowel DiseaseNanja Bevers, Els Van de Vijver, Adrienne Hanssen, et al.
The Journal of Pediatrics|December 23, 2022
Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical TrialNanja Bevers, Els Van de Vijver, Arta Aliu, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Crohn'S & Colitis|May 14, 2021
Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn's DiseaseAshkan Rezazadeh Ardabili, Danny Goudkade, Dion Wintjens, et al.
Alimentary Pharmacology & Therapeutics|July 7, 2022
Classic drugs in the time of new drugs: real-world, long-term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel diseaseAshkan Rezazadeh Ardabili, Steven Jeuring, Zlatan Mujagic, et al.
Digestive Diseases and Sciences|May 24, 2026
Healthcare Providers' Perspectives on the Role of Artificial Intelligence in the Care of Patients with Inflammatory Bowel Disease: An International SurveyJalpa Devi, Colleen Y Colbert, Sophia Haroon Dar, et al.
Plos One|October 5, 2021
Severe COVID-19 in inflammatory bowel disease patients in a population-based settingRob H Creemers, Ashkan Rezazadeh Ardabili, Daisy M Jonkers, et al.
Pediatric Research|July 30, 2024
Explorative study on the value of hepcidin in predicting iron non-responsiveness in paediatric inflammatory bowel diseaseNanja Bevers, Arta Aliu, Ashkan Rezazadeh Ardabili, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2024
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remissionArta Aliu, Daan H C A Bosch, Daniel Keszthelyi, et al.
Journal of Crohn'S & Colitis|July 8, 2025
The Risk of Mild, Moderate, and Severe Infections in IBD patients - A prospective, multicentre observational cohort study (PRIQ)Ashkan Rezazadeh Ardabili, Dirk Van Esser, Dion Wintjens, et al.
Journal of Crohn'S & Colitis|February 16, 2023
Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel DiseaseAshkan Rezazadeh Ardabili, Dirk van Esser, Dion Wintjens, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 26, 2023
Fatigue and Physical Activity Patterns in Children With Inflammatory Bowel DiseaseNanja Bevers, Els Van de Vijver, Adrienne Hanssen, et al.
The Journal of Pediatrics|December 23, 2022
Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical TrialNanja Bevers, Els Van de Vijver, Arta Aliu, et al.
Pageof 2